| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228532 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 8 Pages |
Abstract
In comparison to 3D-CRT and RFA, SBRT was the most cost-effective treatment for medically inoperable NSCLC over a wide range of treatment and disease assumptions. On the basis of efficacy and cost, SBRT should be the primary treatment approach for this disease.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David J. M.D., M.P.H., Jon O. M.D., Rinaa S. M.D., M.P.H.,